Stocks and Investing
Stocks and Investing
Mon, April 5, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sun, April 4, 2021
[ 12:00 AM ] - WOPRAI
Thu, April 1, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Danielle Antalffy Maintained (TNDM) at Hold with Decreased Target to $95 on, Apr 1st, 2021
Danielle Antalffy of SVB Leerink, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Hold with Decreased Target from $115 to $95 on, Apr 1st, 2021.
Danielle has made no other calls on TNDM in the last 4 months.
There is 1 other peer that has a rating on TNDM. Out of the 1 peers that are also analyzing TNDM, all agrees with Danielle's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Lawrence Biegelsen of "Wells Fargo" Downgraded from Buy to Hold and Held Target at $105 on, Tuesday, December 15th, 2020
Contributing Sources